Yoqneam, Israel
Went public 10/04/01 at $12 per share
Filing Range: 5.0 million shares at $12 to $14
Offering Size: $65.0 million
Post Offering Valuation: $300.8 million
Shares Outstanding: 25.1 million shares
Underwriters: Lehman Brothers/Credit Suisse First Boston/ Robertson Stephens & Co./Fidelity Capital Markets
Company Counsel: White & Case LLP
Manager Counsel: Bingham Dana LLP
Auditor: KPMG International
The Company:
Develops wireless imaging systems that provide visual examinations of the gastrointestinal tract. The company’s system uses a miniaturized video camera contained in a capsule that is ingested by the patient and delivers color images in a painless and noninvasive manner.
Venture Backers:
OrbiMed Advisors LLC
Financing Rounds:
Number of Round Amount
Round # Round Date Stage Investors ($ thousands)
1 10/01/2000 1 Early Stage 30000.0
Financials:
(Data in $ million except EPS)
Y/E
12/31/00
Total Revenues: $0.0
Net Income: (7.5)
EPS: (0.68)